InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Lingamneni Anila, Chief Technology Officer. Officer active across 2 companies, notably Haemonetics CORP. Cumulatively, 5 filings have been recorded. Total volume traded: €87k. The latest transaction was disclosed on 19 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€77,3181,384 shares@ €55.86550.0030% mcap88.6% of flow
Common Stock
SEC:0001127602-22-015366:0·
4,340 shares
Common Stock
SEC:0001127602-22-014984:0·
€9,913189 shares@ €52.44960.0004% mcap11.4% of flow
Common Stock
SEC:0001127602-22-012143:0·
3,535 shares
Common Stock
SEC:0001127602-21-017682·
3,535 shares
Common Stock
SEC:0001127602-21-017682:0·
5 of 5 declarations
About Lingamneni Anila
Anila Lingamneni is the Executive Vice President and Chief Technology Officer at Haemonetics Corp, a company specializing in medical technologies. In this role, she oversees technological development and innovation within the company.
